This test is designed for neurological health assessment and risk evaluation. It helps identify neuroinflammation, neurodegeneration, and neuronal injury, but it is not intended to replace a clinical diagnosis.

Not necessarily. Abnormal findings may indicate an increased risk of neuroinflammation, neuronal injury, or neurodegenerative processes, and should be interpreted alongside clinical symptoms and medical evaluation.

Follow-up testing every 6–12 months is generally recommended, depending on individual risk factors, neurological health status, and physician recommendations.

No. The test only requires a peripheral blood sample and does not involve radiation or invasive imaging procedures.

The results can support neurological health management, disease risk assessment, treatment monitoring, and the development of personalized healthcare strategies.

Yes. The test is recommended for children aged 3 years and older, with testing performed under the guidance of a qualified healthcare professional.